Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity

Xiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren · 2026

Read Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity by Xiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13230990.txt.

Description

Xiaohong Yu and colleagues engineer in 2026 a targeted immune booster that revives tired T cells inside colon tumors in mice. Most tumor-specific T cells there carry the brake marker LAG3 and respond poorly to interleukin-2, a growth signal. The team fused a weak form of that signal to a LAG3-seeking part so only those cells receive it.

Treated cells multiplied, shifted toward an active fighter state, and avoided final exhaustion. Tumors shrank and mice lived longer in the model. The treatment also rebuilt a key signaling chain inside the cells by raising a receptor subunit. Fighter and memory cells grew in nearby lymph nodes too, giving protection against distant tumors and return of disease.

Catalog record

CREATORXiaohong Yu, Huiping Liao, Jiaoyun Lv, Yu Sun, Ruiqi Zhang, Yiwei Chen, Yifan Lin, Lulu Liu, Shijie Li, Hui Tang, Panpan Jia, Bin Shao, Zaopeng Yang, Yang-Xin Fu, Zhenhua Ren
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13230990

Browse the full library · About the Tower of Babel